Curcumin attenuates myocardial ischemia–reperfusion injury

Kun Liu; Honglin Chen; Qing-Sheng You; Qing Ye; Fei Wang; Shuo Wang; Shuang-Long Zhang; Kang-Jun Yu; Qi Lu

doi:10.18632/oncotarget.23002

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Curcumin attenuates myocardial ischemia–reperfusion injury

Kun Liu, Honglin Chen, Qing-Sheng You, Qing Ye, Fei Wang, Shuo Wang, Shuang-Long Zhang, Kang-Jun Yu and Qi Lu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:112051-112059. https://doi.org/10.18632/oncotarget.23002

Metrics: PDF 2512 views | HTML 2988 views | ?

Abstract

Kun Liu1, Honglin Chen2, Qing-Sheng You1, Qing Ye3, Fei Wang1, Shuo Wang1, Shuang-Long Zhang1, Kang-Jun Yu1 and Qi Lu4

1Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, P.R. China

2School of Nursing, Nantong University, Nantong, P.R. China

3Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, P.R. China

4Department of Cardiology, Affiliated Hospital of Nantong University, Nantong, P.R. China

Correspondence to:

Qi Lu, email: [email protected]

Keywords: curcumin; myocardial ischemia–reperfusion; inflammation

Received: September 19, 2017 Accepted: November 06, 2017 Published: December 06, 2017

ABSTRACT

Background: Cardiovascular diseases (CVDs) are at a badly high-risk of morbidity and mortality in the world.

Methods: Our study was attempted to investigate the cardioprotective role of curcumin. Hearts injury was assessed in isolated hearts and the rats of coronary artery ligated.

Results and Conclusions: The inhibition of pro-inflammatory cytokines was observed by curcumin in coronary artery ligated rats. ST segment was also reduced by curcumin. Triphenyltetrazolium chloride staining (TTC) staining and pathological analysis were also showed that curcumin could dramatically alleviate myocardial injury. Besides, the results in vitro also demonstrated that curcumin could improved the function of isolated hearts. Besides, the expressions of inflammation-related pathway in both rats and isolated hearts treated with curcumin were significantly decreased. The present study investigated the protective effects of curcumin on myocardial injury and its mechanism.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23002

Publication Alerts

Post-Publication Promotion

Research Papers:

Curcumin attenuates myocardial ischemia–reperfusion injury

Abstract